ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635591 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635591; 2) Community: the network communities that were significantly associated with the response to NSC 635591; 3) Molecule: the relationships between components within communities and NSC 635591; 4) MDR: the compounds that were significantly associated with the NSC 635591.

NSC Compound Enrichment Correlation
NSC 696660 (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.000702054856500155 0.2780174
NSC 744622 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide 0.000702054856500155 0.31021357
NSC 629730 Null 0.000718549049035015 0.49812858
NSC 682561 Cardenolide 2 0.000718549049035015 0.52855116
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.000839001373926613 0.41841034
NSC 33530 Null 0.000839001373926613 0.45874311
NSC 353739 Bismuthine, (acetyloxy)diphenyl- 0.000839001373926613 0.34431105
NSC 381864 PICEATANNOL, 4,3',5'-TRIMETHYL,1S0 0.000839001373926613 0.39067688
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.000839001373926613 0.6283803
NSC 644916 ANTINEOPLASTIC-644916 0.000839001373926613 0.49994132
Total:130  Current:5    [First] [Prev] [Next] [Last]